首页 | 本学科首页   官方微博 | 高级检索  
     

6-[4-(4′-吡啶)氨基苯]-4,5-二氢-3(2H)哒嗪酮对大鼠胸主动脉环收缩功能的影响
引用本文:江其生[1,2] 胡德耀 肖南 刘良明 刘韧 闵家鑫. 6-[4-(4′-吡啶)氨基苯]-4,5-二氢-3(2H)哒嗪酮对大鼠胸主动脉环收缩功能的影响[J]. 中国药理学与毒理学杂志, 2007, 21(1): 17-22
作者姓名:江其生[1  2] 胡德耀 肖南 刘良明 刘韧 闵家鑫
作者单位:[1]第二炮兵总医院中心实验室,北京100088 [2]第三军医大学大坪医院野战外科研究所,重庆400042
基金项目:军队医学科研“九五”重点项目(96L041)
摘    要:目的 研究新型钙增敏强心剂6-[4-(4′-吡啶)氨基苯]-4,5-二氢-3(2H)哒嗪酮(MCI-154)的扩血管作用机制。方法 采用生物张力换能器及生理记录仪测定大鼠离体胸主动脉环和蜕膜胸主动脉环的收缩张力。结果 MCI-154可浓度依赖性抑制1 nmol·L-1~10 μmol·L-1去甲肾上腺素(pD2′为4.21±0.23)和80 mmol·L-1 KCl(IC50为7 μmol·L-1)引起的血管环收缩,提示其可通过抑制血管平滑肌细胞膜上受体操纵性和电压依赖性钙通道而减少胞外钙内流。在无Ca2+ K-H液中,MCI-154预处理可浓度依赖性降低3 μmol·L-1苯肾上腺素(IC50为5 μmol·L-1)及20 mmol·L-1 咖啡因(IC50为16 μmol·L-1)引起的血管环收缩张力,提示其可抑制血管平滑肌细胞胞内钙释放。在1 μmol·L-1 Ca2+溶液中,MCI-154可显著降低蜕膜血管环收缩张力(IC50为10 μmol·L-1),提示其可降低血管平滑肌对Ca2+的敏感性。结论 MCI-154可通过抑制血管平滑肌胞外钙内流、胞内钙释放和降低其对Ca2+敏感性来降低血管平滑肌收缩张力,体外具有扩血管效应。

关 键 词:6-[4-(4′-吡啶)氨基苯]-4,5-二氢-3(2H)哒嗪酮  主动脉, 胸  肌, 平滑, 血管  血管收缩  钙敏感性
收稿时间:2006-03-08
修稿时间:2006-03-08

Effects of 6-[4-(4′-pyridyl)amino-phenyl]-4,5-dihydro-3(2H)-pyridazinone on contraction of aorta in rats
JIANG Qi-Sheng , HU De-Yao, XIAO Nan , LIU Liang-Ming , LIU Ren , MIN Jia-Xin. Effects of 6-[4-(4′-pyridyl)amino-phenyl]-4,5-dihydro-3(2H)-pyridazinone on contraction of aorta in rats[J]. Chinese Journal of Pharmacology and Toxicology, 2007, 21(1): 17-22
Authors:JIANG Qi-Sheng    HU De-Yao   XIAO Nan    LIU Liang-Ming    LIU Ren    MIN Jia-Xin
Affiliation:1. Central Laboratory, the Second Artillery General Hospital, Beijing 100088, China; 2. Institute of Surgery, Daping Hospital, the Third Military Medical University, Chongqing 400042, China
Abstract:AIM To explore the mechanism of vasodilation effect of 6-[4-(4′-pyridyl)-amino-phenyl]-4,5-dihydro-3 ( 2H )-pyridazinone ( MCI-154 ), a novel calcium sensitizer for cardiac contraction protein. METHODS Thoracic aorta rings isolated from rats and tension sensors were used for determining contractile tension in vitro. The skinned aortic rings were produced by α-toxin and used for Ca2+ sensitivity examinaton. RESULTS In H-K solution, 0.01-10 μmol·L-1 MCI- 154 concentration-dependently decreased contraction of aortic rings induced by 1 nmol·L-1-10 μmol·L-1 norepinephrine ( pD2′ 4.21 ± 0.23 ) and 80 mmol·L-1 KCl ( IC50 7 μmol·L-1 ), respectively, it suggested that MCI-154 decrease extracellular Ca2+ influx by receptor-operate Ca2+ channel and potential-dependent Ca2+ channel. In Ca2+ -free H-K solution, 0.01 - 10 μmol·L-1 MCI- 154 significantly reduced contraction of aortic rings initiated by 3 μmol·L-1 phenylephrine ( IC50 5 μmol·L-1 ) and 20 mmol·L-1 caffeine ( IC50 16 μmol·L-1 ), it was revealed that MCI-154 inhibited intracellular Ca2+ release from sarcoplasmic reticulum. In 1 μmol·L-1 Ca2+ solution, 0.01-10 μmol·L-1 MCI-154 remarkably decreased the Ca2+-activated contraction developed in α-toxin- treated skinned aortic rings (IC50 10 μmol·L-1), it was indicated that MCI-154 decreased sensitivity of VSM contractile elements by Ca2+. CONCLUSION MCI- 154 inhibits vascular contraction by decreasing extracellular Ca2+ influx, intracellular Ca2+ release from sarcoplasmic reticulum and sensitivity of VSM contractile elements by Ca2+.
Keywords:6-[4-(4′-pyridyl)amino-phenyl]-4  5-dihydro-3(2H)-pyridazinone  aorta  thoracic  muscle  smooth  vascular  vasoconstriction  calcium sensitivity
本文献已被 维普 等数据库收录!
点击此处可从《中国药理学与毒理学杂志》浏览原始摘要信息
点击此处可从《中国药理学与毒理学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号